Oncology/Hematology

Other Cancers

Latest AI and machine learning research in other cancers for healthcare professionals.

8,952 articles
Stay Ahead - Weekly Other Cancers research updates
Subscribe
Browse Categories
Showing 1941-1960 of 8,952 articles

Identification of Glioma Phenotypic Subtypes From Multimodal MRI Data Using Hierarchical Multi-Kernel Learning.

BACKGROUND: Gliomas are the most common primary brain tumors, exhibiting significant phenotypic variability even within the same grade. Identifying glioma subtypes through non-invasive methods could improve patient management. METHODS: In this study, we applied hierarchical multi-kernel learning to identify glioma phenotypic subtypes using MRI data (T1CE and T2FLAIR) from the First Hospital of Sha...

Feb 1 2026 41621832

Integrating network toxicology, machine learning, and molecular dynamics simulations to reveal tanshinone iia's dual mechanisms in TNBC and doxorubicin-induced cardiotoxicity.

Doxorubicin (Dox)-induced cardiotoxicity remains a critical barrier to optimizing breast cancer (BC) treatment, highlighting the urgent need to dissect its toxicological mechanisms and develop toxicity-mitigating combination strategies; here, we address this gap by integrating network toxicology, molecular dynamics simulations, bioinformatics, and machine learning to unravel how tanshinone IIA (Ta...

Feb 1 2026 41622283
Time-Resolved Fluorescence and Diffuse Reflectance (TRF-DR) Spectroscopy for Heterogeneous Breast Tissue Classification and Tumor Margin Assessment.

Re-excision rates remain high for early-stage breast cancer patients due to challenges in margin delineation during surgery, such as poorly defined tu...

Feb 1 2026 41622347
Overcoming Resistance in EGFR-Mutant Cancers: A Comprehensive Review of Inhibitor Evolution and SAR-Based Design.

The epidermal growth factor receptor (EGFR) is a key target in cancer therapy, mainly in non-small cell lung cancer (NSCLC). Though, the efficacy of E...

Feb 1 2026 41486501
Multi-omics predicts radiotherapy response in small cell lung cancer patients receiving whole brain irradiation.

OBJECTIVE: Dosiomics and radiomics elaborate the low-and high-order features extracted from images to predict clinical outcomes. Whole-brain radiother...

Feb 1 2026 41571595
Minimal residual disease in solid tumors: Clinical applications and future directions.

Minimal residual disease (MRD) refers to the presence of residual cancer cells or tumor-derived fragments that persist after treatment and remain unde...

Feb 1 2026 41604278
The Immuno-Metabolic Crosstalk in Lung Squamous Cell Carcinoma: Prognostic Insights and Therapeutic Clues.

Lung squamous cell carcinoma (LUSC) has a poor prognosis due to the lack of effective targeted therapies, and its incidence has increased dramatically...

Feb 1 2026 41606426
Comprehensive tumour-immune profiling reveals TREM2+ tumour-associated macrophages facilitating lymph node metastasis in head and neck squamous cell carcinoma.

BACKGROUND: Lymph node (LN) metastasis is a well-established independent prognostic factor in head and neck squamous cell carcinoma (HNSCC). Formation...

Feb 1 2026 41612852
Targeted blood proteome profiling using NULISAseq identifies a high-performance biomarker panel for Aβ pathology quantification and staging.

INTRODUCTION: While current blood-based biomarkers for Alzheimer's disease (AD) are effective for determining amyloid beta (Aβ) pathology positivity/n...

Feb 1 2026 41612914
Pharmacokinetics and Customized Dosing of Vancomycin in Adult Patients With Hematological Malignancies: Status, Challenges, and Opportunities.

Vancomycin (VAN) remains the first-line treatment for methicillin-resistant, multidrug-resistant gram-positive bacterial infections, even among cancer...

Feb 1 2026 41618547
Intelligent multi omics and industry 6.0 and 7.0 enabled technologies for deciphering the tumor immune microenvironment and advancing cancer immunotherapy.

Recent advancements in cancer immunotherapy have transformed clinical oncology, with monoclonal antibodies (mAbs), immune checkpoint inhibitors, adopt...

Jan 31 2026 41623584
A novel signature of palmitoylation for predicting prognosis and therapeutic response of hepatocellular carcinoma.

Hepatocellular carcinoma (HCC) represents an extremely complex and heterogeneous malignant tumor. Protein palmitoylation, a highly conserved and pivot...

Jan 31 2026 41619135
Prediction of mortality, bleeding, and ischaemic events in patients with cancer and acute coronary syndrome: a model development and validation study.

BACKGROUND: Accurate assessment of mortality, bleeding, and atherothrombotic risk in patients with cancer and acute coronary syndrome could inform nov...

Jan 31 2026 41620233
ACACA modulates R-loop homeostasis to enhance lipid metabolism and microenvironmental interactions in ccRCC.

R-loops are dynamic nucleic acid structures implicated in genome regulation and instability, yet their contributions to the tumor microenvironment (TM...

Jan 31 2026 41620551
RNA modifications in cancer and their detection: a review.

Ribonucleic acid (RNA) modifications, once viewed as static structural features, are now recognized as dynamic regulators of the 'epitranscriptome' th...

Jan 30 2026 41615068
Deep learning for early diagnosis of uveal melanoma: a systematic review and meta-analysis.

BACKGROUND: Uveal melanoma (UM) is a rare cancer with an estimated annual incidence of 6 incidences per million people. About half of UM patients deve...

Jan 30 2026 41615646
Incorporating artificial intelligence into imaging for surveillance and diagnosis of liver cancer: Innovations, challenges, and clinical translation.

Primary liver cancer, mainly hepatocellular carcinoma and intrahepatic cholangiocarcinoma, remains a leading cause of cancer mortality worldwide. Earl...

Jan 30 2026 41616271
Clinical Validation of Deep Learning-Accelerated versus Wave-CAIPI Postcontrast 3D T1-MPRAGE for Evaluation of Intracranial Enhancing Lesions.

BACKGROUND AND PURPOSE: Deep learning (DL) reconstruction methods have shown promise in accelerating 2D MRI sequences but have yet to be extensively v...

Jan 30 2026 41617400
XRepDDA: An Interpretable Drug-Disease Association Prediction Framework Leveraging Pretrained Chemical Language Models.

Drug repositioning aims to identify new indications for existing drugs, offering a cost-effective and time-efficient strategy for therapeutic developm...

Jan 30 2026 41617662
Browse Categories